Cairo University Completes Clinical Study NCT05579535 on Gait Intervention for Pediatric Spastic Diplegia
Cairo University has completed clinical study NCT05579535, investigating the effect of ankle weights on hip excursion in children with spastic diplegia. This interventional study, led by Nahla Mohamed Ibrahim, provides critical data for non-pharmacological approaches in pediatric neurological rehabilitation. Decision-makers should monitor results for potential impacts on physical therapy protocols and rehabilitation product development.
Clinical Study Completion: Cairo University's Gait Intervention for Spastic Diplegia
Cairo University, an academic institution based in Egypt, has officially completed its interventional clinical study, NCT05579535, titled 'Effect of Weight on Hip Excursion During Gait in Children With Diplegia.' The study, which commenced on August 3, 2022, and reached its primary completion date on October 3, 2022, with overall completion by October 7, 2022, focused on a critical aspect of pediatric neurological rehabilitation: managing gait abnormalities in children diagnosed with spastic diplegic cerebral palsy. The principal investigator, Nahla Mohamed Ibrahim, a lecturer at the pediatric department, faculty of physical therapy at Cairo University, led this research effort. The trial was designed as a randomized, parallel-group study with single masking (participants were masked) to investigate the efficacy of using weight around the ankle during gait training. This approach aimed to specifically assess its impact on hip excursion, a key biomechanical parameter in the gait cycle. For procurement directors and business development executives, this completion signals a potential shift or reinforcement in non-pharmacological treatment modalities, which could influence demand for specific rehabilitation equipment or training programs in the future. The study’s focus on a specific, measurable outcome like hip excursion provides a clear metric for evaluating intervention effectiveness, which is valuable for evidence-based practice.
Therapeutic Implications for Pediatric Neurological Conditions
The completed study NCT05579535 directly addresses the indication of 'Gait, Spastic,' a common challenge in pediatric neurology. Children with diplegia often exhibit considerably larger hip and knee excursion during gait compared to typically developing children, necessitating targeted interventions. This trial explored a practical, non-invasive physical therapy technique: incorporating ankle weights into gait training. Fifty children, aged 7 to 10 years, diagnosed with spastic diplegia and classified as level II on the Gross Motor Function Classification System (GMFCS), were enrolled. They were randomized into two groups: one receiving classical gait training (Group A) and another receiving gait training with ankle weights (Group B). Both groups underwent one-hour sessions, three times per week, for three consecutive months. For regulatory affairs heads, the non-pharmacological nature of this intervention means it falls outside typical drug or device regulatory pathways, as confirmed by its `isFdaRegulatedDrug: false` and `isFdaRegulatedDevice: false` status. However, the outcomes, once published, could inform clinical practice guidelines and potentially influence the design and adoption of rehabilitation protocols globally. Supply chain VPs should note that successful results could drive demand for specific types of weighted rehabilitation equipment, impacting sourcing strategies for physical therapy clinics and hospitals.
Research Landscape and Future Directions in Physical Rehabilitation
The completion of Cairo University's study NCT05579535 contributes to the growing body of evidence in physical rehabilitation, particularly for neurological conditions. While the study results are not yet publicly available (`hasResults: false`), its completion marks a significant milestone in understanding adjunctive therapies for spastic gait. The methodology, involving two-dimensional (2D) gait analysis for objective measurement of hip excursion, underscores a commitment to quantitative assessment in physical therapy. This aligns with a broader industry trend towards data-driven clinical outcomes. For business development executives, this highlights an active area of academic research that, while not directly a drug approval, could generate insights for new medical device innovations or service offerings in pediatric rehabilitation. The focus on a specific, measurable biomechanical outcome provides a clear target for future research or product development. The broader clinical research landscape, as evidenced by recent parallel events such as AbbVie's FDA approval for RINVOQ LQ or Dr. Falk Pharma's Phase III trial completion for Budesonide, demonstrates continuous innovation across diverse therapeutic areas, including both pharmacological and non-pharmacological interventions. This Cairo University study, though distinct in its focus, reinforces the global commitment to advancing patient care through rigorous clinical investigation.
Operational Insights for Clinical Trial Management and Data Transparency
From an operational standpoint, the Cairo University study NCT05579535 offers valuable insights for clinical trial management and data transparency. The trial was sponsored by Cairo University, with Nahla Mohamed Ibrahim serving as the principal investigator, highlighting an academic-led research model. The study was conducted in Giza, Egypt, indicating regional capabilities in clinical research. Crucially, the trial maintained robust oversight, confirmed by `oversightHasDmc: true`, signifying the presence of a Data Monitoring Committee to ensure patient safety and data integrity. For regulatory affairs heads and procurement directors involved in clinical operations, the explicit statement regarding data sharing is noteworthy: the study protocol and other information types will be available upon contacting the corresponding author after online publication. This commitment to `ipdSharing: YES` and the provision of `infoTypes: [STUDY_PROTOCOL]` sets a precedent for transparency in academic research, enabling broader scientific scrutiny and potential meta-analyses. Understanding these operational details is vital for organizations considering collaborations in emerging research hubs or for those benchmarking best practices in clinical trial governance and data dissemination, particularly for studies that are not subject to stringent FDA or EMA drug/device regulations but still adhere to ethical and scientific standards.
Strategic Considerations for Rehabilitation Product Development
While this clinical study did not involve a pharmaceutical product or a regulated medical device, its findings, once published, could significantly influence strategic planning for companies in the rehabilitation and medical equipment sectors. The intervention — using weight around the ankle during gait training — directly points to a potential market for specialized weighted devices or integrated rehabilitation systems. Business development executives should consider how positive outcomes from this study could stimulate demand for ergonomically designed ankle weights, smart wearable devices that monitor gait parameters, or comprehensive physical therapy programs incorporating such techniques. The focus on children aged 7-10 years with spastic diplegia also defines a specific patient demographic, allowing for targeted product development and marketing strategies. Furthermore, the use of 2D gait analysis as a primary outcome measure suggests an opportunity for companies developing diagnostic and monitoring tools for gait abnormalities. Procurement directors in healthcare systems should anticipate potential future requirements for such non-pharmacological aids, necessitating proactive engagement with suppliers of rehabilitation equipment to ensure access to evidence-based tools. This study underscores the importance of monitoring academic research for signals that can drive innovation and market shifts in adjunctive therapies.